Stanley M H Chan, Kurt Brassington, Suleman Abdullah Almerdasi, Aleksandar Dobric, Simone N De Luca, Madison Coward-Smith, Hao Wang, Kevin Mou, Alina Akhtar, Rana Abdullah Alateeq, Wei Wang, Huei Jiunn Seow, Stavros Selemidis, Steven Bozinovski, Ross Vlahos
BACKGROUND AND PURPOSE: Cardiovascular disease (CVD) affects up to half of the patients with chronic obstructive pulmonary disease (COPD), and exerts deleterious impact on health outcomes and survivability. Vascular endothelial dysfunction marks the onset of cardiovascular disease. The present study examined the effect of a potent NADPH Oxidase (NOX) inhibitor and free-radical scavenger, apocynin, on COPD-related CVD. EXPERIMENTAL APPROACH: Male BALB/c mice were exposed to either room air (Sham) or cigarette smoke (CS) generated from 9 cigarettes per day, 5 days a week for up to 24 weeks with or without apocynin treatment (5 mg·kg-1 ·day-1 , intraperitoneal injection)...
March 12, 2023: British Journal of Pharmacology